| scholarly article | Q13442814 |
| P50 | author | Fin S Larsen | Q42861884 |
| P2093 | author name string | Lars E Schmidt | |
| Lars Peter Wang | |||
| Bent A Hansen | |||
| P433 | issue | 3 | |
| P921 | main subject | patient | Q181600 |
| liver failure | Q970208 | ||
| hemodynamics | Q1642137 | ||
| P304 | page(s) | 290-297 | |
| P577 | publication date | 2003-03-01 | |
| P1433 | published in | Liver Transplantation | Q15730498 |
| P1476 | title | Systemic hemodynamic effects of treatment with the molecular adsorbents recirculating system in patients with hyperacute liver failure: a prospective controlled trial | |
| P478 | volume | 9 |
| Q79751936 | Acute liver failure |
| Q36473219 | Albumin regeneration in liver support-comparison of different methods |
| Q38484584 | An Australian experience with the molecular adsorbents recirculating system (Mars). |
| Q37930642 | Artificial extracorporeal liver support therapy in patients with severe liver failure |
| Q38481056 | Artificial liver support with the molecular adsorbent recirculating system: activation of coagulation and bleeding complications. |
| Q36392462 | Bench-to-bedside review: current evidence for extracorporeal albumin dialysis systems in liver failure |
| Q38466400 | Comparison of the Molecular Adsorbent Recirculating System and Plasmapheresis for Patients With Graft Dysfunction After Liver Transplantation |
| Q38451211 | Development of high-efficiency molecular adsorbent recirculating system: preliminary report |
| Q41840433 | Dialysis reduces portal pressure in patients with chronic hepatitis C. |
| Q34768560 | Effect of Prometheus liver assist system on systemic hemodynamics in patients with cirrhosis: a randomized controlled study |
| Q33208253 | Effect of an experimental stenosis in the porcine descending thoracic aorta |
| Q38432418 | Effectiveness and Safety Assessment of Citrate Anticoagulation During Albumin Dialysis in Comparison to Other Methods of Anticoagulation |
| Q24801094 | Equipment review: the molecular adsorbents recirculating system (MARS) |
| Q34719069 | Evaluation of the Hepa Wash® treatment in pigs with acute liver failure |
| Q34793181 | Evidence and consequences of spectrum bias in studies of criteria for liver transplant in paracetamol hepatotoxicity |
| Q37846058 | Extracorporeal liver support |
| Q38702799 | Extracorporeal liver support devices for listed patients |
| Q38740963 | Extracorporeal support for patients with acute and acute on chronic liver failure |
| Q36283332 | First clinical experience in 14 patients treated with ADVOS: a study on feasibility, safety and efficacy of a new type of albumin dialysis |
| Q37723358 | Hypoxic hepatitis - epidemiology, pathophysiology and clinical management |
| Q38552177 | Hypoxic hepatitis: a challenging diagnosis |
| Q38455566 | Lipocalin-2 serum levels are increased in acute hepatic failure. |
| Q92872800 | Liver Injury and Failure in Critical Illness |
| Q44609373 | Liver support in acute liver failure |
| Q36335206 | Liver support systems: promise and reality |
| Q38080028 | Liver support systems: will they ever reach prime time? |
| Q35750315 | Liver transplantation reverses hypergammaglobulinemia in patients with chronic hepatic failure |
| Q38487392 | MARS (Molecular Adsorbents Recirculating System). New technique of extracorporeal depuration in liver failure |
| Q50854199 | MARS and the failing liver-Any help from the outer space? |
| Q38473987 | MCP-1 and MIP3-alpha serum levels in acute liver failure and molecular adsorbent recirculating system (MARS) treatment: a pilot study |
| Q26771851 | Meta-analysis of survival with the molecular adsorbent recirculating system for liver failure |
| Q38479704 | Modifications of intracranial pressure after molecular adsorbent recirculating system treatment in patients with acute liver failure: case reports |
| Q38461421 | Molecular Adsorbents Recirculating System dialysis in children with cholestatic pruritus |
| Q34999188 | Molecular adsorbent recirculating system and hemostasis in patients at high risk of bleeding: an observational study |
| Q38482166 | Molecular adsorbent recirculating system in liver transplantation: Safety and efficacy. |
| Q38483430 | Molecular adsorbent recirculating system treatment for patients with liver failure: the Hong Kong experience |
| Q38470239 | Nucleosome serum levels in acute hepatic failure and MARS treatment |
| Q36257253 | Outcome from molecular adsorbent recycling system (MARS) liver dialysis following drug-induced liver failure |
| Q33995791 | Personal view: current role of artificial liver support devices |
| Q34708388 | Randomized controlled study of extracorporeal albumin dialysis for hepatic encephalopathy in advanced cirrhosis. |
| Q38226627 | Recommendations for the management of acute hepatitis B: position paper of the Italian Society for the Study of Infectious and Tropical Diseases (SIMIT). |
| Q51746847 | Regional citrate anticoagulation in patients with liver failure supported by a molecular adsorbent recirculating system* |
| Q36372530 | Review article: non-biological liver support in liver failure. |
| Q37356310 | Role of artificial liver support in hepatic encephalopathy |
| Q38478877 | Safety and efficacy of the MARS therapy applied by continuous renal replacement therapy (CRRT) monitors |
| Q51930408 | Systemic and regional hemodynamics in pigs with acute liver failure and the effect of albumin dialysis. |
| Q82540686 | The Effect of Prometheus Device on Laboratory Markers of Inflammation and Tissue Regeneration in Acute Liver Failure Management |
| Q36423222 | The Molecular Adsorbent Recirculating System (MARS) in the intensive care unit: a rescue therapy for patients with hepatic failure |
| Q38486797 | The effect of molecular adsorbent recirculating system on pathophysiological parameters in patients with acute liver failure. |
| Q38058139 | The kidney in pediatric liver transplantation: an updated perspective |
| Q55019787 | The molecular adsorbent recirculating system in posthepatectomy liver failure: Results from a prospective phase I study. |
| Q38062342 | The role of molecular adsorbent recirculating system dialysis for extracorporeal liver support in children |
| Q35782626 | The role of the Molecular Adsorbents Recirculating System (MARS) in the management of liver failure |
| Q35176933 | Therapeutic plasma exchange does not reduce vasopressor requirement in severe acute liver failure: a retrospective case series |
| Q33395093 | Thromboelastography to monitor clotting/bleeding complications in patients treated with the molecular adsorbent recirculating system |
| Q37605883 | Treatment of hepatorenal syndrome. |
| Q87691018 | Understanding paracetamol-induced liver failure |
| Q37955184 | Use of the molecular adsorbent recirculating system (MARS™) for the management of acute poisoning with or without liver failure |
| Q75198763 | [Liver replacement therapy. Reliable indications in acute liver failure] |
Search more.